Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19, updated 18 August 2022

These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.

This document has been updated: Version 23 February 2022

Auteurs